140 related articles for article (PubMed ID: 20138101)
1. Quantitative and statistical analysis of differences in sensitivity between Long-Evans and Han/Wistar rats following long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Sand S; Fletcher N; von Rosen D; Kalantari F; Viluksela M; Tuomisto JT; Tuomisto J; Falk-Filipsson A; Håkansson H
Regul Toxicol Pharmacol; 2010; 57(2-3):136-45. PubMed ID: 20138101
[TBL] [Abstract][Full Text] [Related]
2. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.
Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J
Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships and dose responses of polychlorinated dibenzo-p-dioxins for short-term effects in 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant and -sensitive rat strains.
Simanainen U; Tuomisto JT; Tuomisto J; Viluksela M
Toxicol Appl Pharmacol; 2002 May; 181(1):38-47. PubMed ID: 12030841
[TBL] [Abstract][Full Text] [Related]
4. Quantitative characterization of changes in bone geometry, mineral density and biomechanical properties in two rat strains with different Ah-receptor structures after long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Herlin M; Kalantari F; Stern N; Sand S; Larsson S; Viluksela M; Tuomisto JT; Tuomisto J; Tuukkanen J; Jämsä T; Lind PM; Håkansson H
Toxicology; 2010 Jun; 273(1-3):1-11. PubMed ID: 20403408
[TBL] [Abstract][Full Text] [Related]
5. TCDD dysregulation of 13 AHR-target genes in rat liver.
Watson JD; Prokopec SD; Smith AB; Okey AB; Pohjanvirta R; Boutros PC
Toxicol Appl Pharmacol; 2014 Feb; 274(3):445-54. PubMed ID: 24355419
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains.
Pohjanvirta R; Viluksela M; Tuomisto JT; Unkila M; Karasinska J; Franc MA; Holowenko M; Giannone JV; Harper PA; Tuomisto J; Okey AB
Toxicol Appl Pharmacol; 1999 Feb; 155(1):82-95. PubMed ID: 10036221
[TBL] [Abstract][Full Text] [Related]
7. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on liver phosphoenolpyruvate carboxykinase (PEPCK) activity, glucose homeostasis and plasma amino acid concentrations in the most TCDD-susceptible and the most TCDD-resistant rat strains.
Viluksela M; Unkila M; Pohjanvirta R; Tuomisto JT; Stahl BU; Rozman KK; Tuomisto J
Arch Toxicol; 1999 Aug; 73(6):323-36. PubMed ID: 10447560
[TBL] [Abstract][Full Text] [Related]
8. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats.
Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT
Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584
[TBL] [Abstract][Full Text] [Related]
9. Altered retinoid metabolism in female Long-Evans and Han/Wistar rats following long-term 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treatment.
Fletcher N; Giese N; Schmidt C; Stern N; Lind PM; Viluksela M; Tuomisto JT; Tuomisto J; Nau H; Håkansson H
Toxicol Sci; 2005 Aug; 86(2):264-72. PubMed ID: 15858224
[TBL] [Abstract][Full Text] [Related]
10. Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity.
Boutros PC; Yao CQ; Watson JD; Wu AH; Moffat ID; Prokopec SD; Smith AB; Okey AB; Pohjanvirta R
Toxicol Appl Pharmacol; 2011 Mar; 251(2):119-29. PubMed ID: 21215274
[TBL] [Abstract][Full Text] [Related]
11. Dose response and time course of alterations in tryptophan metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-susceptible and the most TCDD-resistant rat strain: relationship with TCDD lethality.
Unkila M; Pohjanvirta R; MacDonald E; Tuomisto JT; Tuomisto J
Toxicol Appl Pharmacol; 1994 Oct; 128(2):280-92. PubMed ID: 7940543
[TBL] [Abstract][Full Text] [Related]
12. Developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-resistant and -susceptible rat strains.
Huuskonen H; Unkila M; Pohjanvirta R; Tuomisto J
Toxicol Appl Pharmacol; 1994 Feb; 124(2):174-80. PubMed ID: 8122262
[TBL] [Abstract][Full Text] [Related]
13. Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain.
Korkalainen M; Tuomisto J; Pohjanvirta R
Biochem Biophys Res Commun; 2004 Feb; 315(1):123-31. PubMed ID: 15013435
[TBL] [Abstract][Full Text] [Related]
14. Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effect on aryl hydrocarbon receptor expression in a dioxin-resistance model.
Franc MA; Pohjanvirta R; Tuomisto J; Okey AB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):43-53. PubMed ID: 11509025
[TBL] [Abstract][Full Text] [Related]
15. Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Yao CQ; Prokopec SD; Watson JD; Pang R; P'ng C; Chong LC; Harding NJ; Pohjanvirta R; Okey AB; Boutros PC
Toxicol Appl Pharmacol; 2012 Apr; 260(2):135-45. PubMed ID: 22342509
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
18. Dose-response analysis of short-term effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in three differentially susceptible rat lines.
Simanainen U; Tuomisto JT; Tuomisto J; Viluksela M
Toxicol Appl Pharmacol; 2003 Mar; 187(2):128-36. PubMed ID: 12649045
[TBL] [Abstract][Full Text] [Related]
19. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
20. Effect of TCDD on mRNA expression of genes encoding bHLH/PAS proteins in rat hypothalamus.
Korkalainen M; Lindén J; Tuomisto J; Pohjanvirta R
Toxicology; 2005 Mar; 208(1):1-11. PubMed ID: 15664428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
